<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 136 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page135.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=136">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 136 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 136</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=136"><img src="../thumb/136.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Cardio-Vascular Agents - 7.3.8                                                 2020-04 / 105
       palpit., tachycard., abdom.pain, dry mouth, hepatit., jaund., pancre-  AUSTELL-LISINOPRIL, Austell [P/S]  Dosage: Admin.bef.meals.
       atit., mood alterat., ment. confus., paraesthes., vertigo, bronchosp.,   Lisinopril.  Mild to mod.hypertens: Recomm.dos: 4 mg dly. bef. breakf., may
       rhinit., sinusit., urticar., diaphores., alopec., prurit., psorias., sev.skin   Indications: Mild to mod.hypertens., adjunct in congest.HF., aft.  be incr. if necess.to 8 mg as sngl. dos.aft.1 mnth.treatm.
       disords./uraemia, oligur./anur., ren.dysfunct., ac.ren.fail., impot.,   ac.MI  CHF: Init. 2 mg as sngl.dos.in morn., may be incr.to 4 mg once
       sympt.complex, photosens., bld.dyscras., hyperkalaem.  (S3) TABS, 38/7.1.3/0032, 37/7.1.3/0392  BP accept.
       Special precautions: Symptomat.hypotens., vol./salt deplet.pts.,   712598-001: 10 mg, 30, R29,97  Contraindications: Angioed.hist.assoc.with prev. ACE-inhibit.
       if poss.discont.diuret. 2-3 day bef.start.treatm., MI pts.at risk of furth.  708189-001: 20 mg, 30, R29,97  ther./angiotens.recept.block.ther., heredit./idiopath.angioed., hy-
       ser. haemodynam. deteriorat.aft.treatm.with a vasodilat., ac.ren.fail./  Dosage: Admin.as sngl.dly dos.  pertroph. obstruct. cardiomyopathy, sev.ren.funct.impairm.(creatin.
       impairm., diabet.mellit., renovasc.hypertens., anaphylactoid reacts.  Mild to mod.hypertens: Init.10 mg with effect. maint.dos.of 20 mg/  clear.&lt; 30 ml/min.), sngl./bilat.ren.arterystenos., aort. stenos., con-
                                                                     +
       in pts. being desensitis.with hymenoptera venom.& receiv. ACE   day sngl.dos. Max.40 mg/day. Full therapeut.eff.aft. sev.wks.theref.  com.K  spar.diuret.ther., porphyr., Addison’s dis.in combin.with fix.
       inhibit.& in pts.on haemodialys.using cert.high-flux membr., black   incr.dos.aft.2-4 wks. if desir.respons.not achiev.  dos. thiazide diurets., anur., sulphonamid.-deriv.med. hypersens.,
       pts., surg., elderly, anaeshes., furth.deteriorat.in ren.funct.of pts.  Pts.on diuret: Init: 5 mg/day. Adjust accord.to respons.  concom.Li, pregn., safety dur.lactat. & in childr.not est., no exper.
       with comprom.ren.funct.       Congest.heart fail: Init.2,5 mg dly. Incr.at 4 wk. interv. till therapeut.  with rec.kidn.transpl.
       Drug interactions: Hypotens.eff.enhanc.by diurets. & other   eff. Maint.dos: 5-20 mg/day.  Side effects: Hypotens., bld.dyscras., psych. disords., CNS effs.,
       hypotens.-produc.meds., indomethacin dimin.act., Li-elim.dimin.,   Ac.MI: Start treatm.within 24 hrs.of sympt.onset. Init.5 mg follow.  headache, dizzin., vertigo, paraesthes., vis./taste disturbs., tinnit.,
       K-supplem., K-spar.diuret./K-contain.salts partic.in ren. dysfunct.  by 5 mg aft.24 hrs.then 10 mg aft.48 hrs. & then 10 mg once dly.x6   dysrhythm., ang.pect., MI, stroke, orthostat.eff., palpitat., non-prod-
       may incr.ser.K.               wks. In case of hypotens.admin.5 mg dly. as maint.dos.reduc. tem-  uct./persist.cough, dyspn., bronchosp., eosinophil.pneum., rhinit., GI
                                     por.to 2,5 mg if neccess.    disturbs., dry mouth, pancreatit., hepatocellul.injur., hepatit., skin
       ADCO-ZETOMAX CO, AI Pharm Ltd &  Contra-indications: Angioed.hist.relat.to prev. ACE inhib., heredit./  reacts.incl.erythema multiforme, angioed.of face/ extremit./lips/
       Lisinopril, hydrochlorothiazide  idiopath.angioed., aort.stenos., hypertroph.obstruct.cardiomyopathy,   mucous membr./tong./glottis &/ larynx., ren.insuffic./ac.ren.fail.,
       Indications: Mild to mod.hypertens.in pts. stabilis. on their indiv.  sev.ren.funct. impairm., ren.artery stenos.in pts.with sngl.kidn., com-  sev.HF/ renovasc. hypertens., musc.cramps, impot., asthen., sweat.,
       compon.in same proport.       con.K -spar.diuret., porphyr., safety & effic.in childr. not est., pregn.,   hyperkalaem., syndr.start.with cholest. jaund.progress.to hepat.ne-
                                       +
       (S3) TABS. 37/7.1.3/0160, 0162  safety in lactat.not est.  cros.& somet. death.
       704597-001: 10/12,5 mg, 30, R53,40  Side effects: Bld.dyscras., CV effs., CNS effs., hyperkalaem., hy-  Special precautions: Treatm.to be stopp.& chang.if pregn.occurs,
       704598-001: 20/12,5 mg, 30, R92,70  ponatraem., GI disturbs., uraem., oligur., anuria, ren.dysfunct., ac.ren.  cons.alter.meds.if pregn. contempl., pass. through placenta with foet.
       Dosage: One tab (of 10/12,5 mg OR 20/12,5 mg strength) once   fail., impot., hepatit., jaund., asthen., cough, bronchosp., rhinit., si-  abnormalit.report.aft.admin.in 2  & 3  trimest.& incr.birth defect risk
                                                                                  rd
                                                                                nd
       dly. Max: 2 tabs (of 10/12,5 mg OR 20/12,5 mg strength) once dly.  nusit., skin reacts. incl.tox.epiderm.necrolys./ Stev-John.syndr./ery-  if admin. dur.1  trimest., elderly/ dehydrat.pts., CHF, concom.diurets.,
                                                                        st
       Contraindications: Anur., hist.of angioed.with ACE-inhibit., heredit./  thema multiforme, hypersens. reacts.& sympt.complex incl.posit.  discont.treatm.1 day bef.maj.surg./anaesthes., monit.glycaem.contr.
       idiopath.angioed., sulphonam. sens., pregn.& lactat., aortic.stenos./   antinuclear antibody  esp. dur.1  mnth.in diab. mellit., correct vol./salt-deplet.bef.init.ther.,
                                                                      st
       hypertroph. cardiomyopathy, bi-./unilat.ren.art. stenos. in pres.of sngl.  Special precautions: Cerebrovas./ ischaem. heart dis., salt & vol.  Li-toxic.risk, monit.init.ther./dos.adjustm.in symptom. hypotens./cer-
       kidn., safety & effic.in childr. not est.  deplet.pts., sev.autoimmun. dis. esp.SLE/other collag.vasc.dis.&   ebrovasc./ischaem.heart dis., discont.treatm.immed.if sev.hypers-
       Side effects: Angioed., symptomat.hypotens., GI disturbs., CNS   scleroderma, symptomat. hypotens., ac MI if ren.fail.evid./if pt. at   ens.reacts.& init.appropr.ther., incr.angioed.risk with angioed. hist.
       effs., paraesthes., asthen., vertigo, fev., mood alterat., ment.confus.,   risk of furth.ser.haemodynam.deteriorat.aft. treatm. with vasodilat.,   unrelat.to ACE inhibits.ther., diet.salt restrict., reg.ser.K monit.with
                                                                                         +
       musc.cramps & weakn., hyperglycaem., jaund., hepatit., pancreatit.,   bone marr.depress., diab. mellit., hyperkalaem., renovasc.dis., bil.ren.  concom. K spar.diurets./ K supplem./K -contain.salt substit., mitr.
                                                                              +
                                                                                   +
                                                                       +
       dry cough, resp.distress., anaphylact. reacts., palpitat., chest discomf.,   artery stenos/arter.stenos.to sngl kidn./ren.transplant, ren.impairm.,   valve stenos., (L) ventr.outflow obstruct., renin-depend. hypertens.,
       bronchosp., rhinit., sinusit., MI & CVA second.to excess. hypotens.  anaphylact.reacts.dur.hymenoptera desens. treatm.& dur.haemodi-  haemodialys.with high flux membr., incr. angioed.incid.in black pts.,
       in high risk pts., tachycard., vasculit., ren. fail./dysfunct., interstit.ne-  alys. proced.with high flux membr./low-dens.lipoprot apheres.with   low-dens.lipoprot. apheres., anaphylact.reacts.dur.hymenoptera
       phrit., skin rash, photosens., psorias.& sev.skin disords., alopec., pru-  dextr.sulf.absorpt., high.incid.of angioed.in black pts., teratogenic.as-  desensitisat.treatm., mark.hepat.enzym.elev./ jaund., monit.infect.
       rit., bld.disords., xanthops., trans.blurr.vis., gout/hyperuricaem., elec-  soc.with expos.aft.1  trimest., discont.diuret.2-3 day bef.start.treatm.  signs.& WBC count in case of collag. vasc.dis./immunosuppress.
                                             st
       trol.imbal., anorex., taste disturbs., sialadenit., impot., angioneurot.  to minim. hypotens.risk, renovascul.hypertens., surg.  ther. /allopurinol &/procainamide treatm., hyperkalaem. risk, ren.
       oed., sympt. complex, bone marr. depress., urin.Ca excret.decr., incr.  Drug interactions: Addit.eff.with hypotens.-produc. meds., in-  funct.impairm., ac.MI., lact.intol.
       triglycerid./cholestrol lev., exacerb./activ.SLE.  domethacin.& NSAID’s dimin. act., hyperkalaem.with K -spar.diu-  Drug interactions: Hypotens.eff.incr.by other antihypertens./ nitro-
                                                             +
       Special precautions: Concom.K-supplem., K-spar./ contain.agents,   ret., Li conc.incr.  glycer. & other nitrat./other vasodilat./ diurets./TCA’s/antipsychot./
       poss.dos.adjustm.of anti-diab. meds., vol./salt deplet.pts., if poss.dis-  cert. anaesthet., poss.incr.ser.K with K spar.diurets./ K supplem./
                                                                                          +
                                                                                   +
                                                                                +
       cont. diuret.2-3 day bef.start.treatm., init.ther.in ren. insuffic., fluid/  AUSTELL-RAMIPRIL, Austell [P/S]  K -cont.salt substit., addit. hyperkalaem. eff.with other meds.caus.
                                                                   +
       electrol.imbal., ischaem.heart dis., cerebrovasc. dis., discont.if incr.bld.  Ramipril  hyperkalaem., poss.ser.Li incr., antihypertens.eff. reduc. by NSAID’s,
       urea & ser. creatinine occur with no appar.pre-exist.ren.dis., anaphy-  Indications: Mild to mod.hypertens., card.fail. follow.MI., reduc.  incr.bld.gluc.low.eff./ hypoglycaem. risk with antidiab.agents,poss.
       lactoid reacts.exper.in concom. haemodialys. proced.using high-flux   proteinur.& glomerul.filtrat.rate decline in diabet.nephropathy &   reduc. antihypertens.eff.with sympathomimets.
       membran.& densensitisat.treatm., imp.hepat.funct./progress. liv. dis.,   hyperten., reduc. risk. of.MI. stroke, or card.vasc.death & need for
       maj.surg./anaesth., angioed.hist., incr. incid. of angioed.in black pts.  revascularisat.proced.in pts with incr.CV risk, reduc. risk.of.MI/stroke,   BIO-CAPTOPRIL, Biotech [P/S]
       Drug interactions: K+ decr.from thiaz.diuret. attentuat., Li clear.  or card.vasc.death in. diab. pt.  Captopril
       reduc.incr.Li toxic.risk, indomethac. may dimin.antihypertens.effic.,   (S3) CAPS. A39/7.1.3/0239, 0240, 0241, 0242  Indications: Mild to mod.hypertens.alone or in combinat., congest.
       furth. deteriorat.in ren.funct.of pts.with comprom.ren. funct.receiv.  705752-001: 1,25 mg, 30, R104,45  heart fail.not respond./adeq. control.by convent.ther.
       NSAID’s, NSAID may reduc.eff., incr. responsiven.to tubocurar., ad-  705753-001: 2,5 mg, 30, R128,87  (S3) TABS, 31/7.1/0658
       dit.eff.with other anti-hypertens.agents, alcoh., barbits.& narcot.  705754-001: 5 mg, 30, R193,39  852333-005: 25 mg, 60, R24,35
       may potent. orthostat.hypotens., corticoster.& ACTH intens.electrol.  705755-001: 10 mg, 30, R63,27  Dosage: Indiv.`
       deplet., poss.decr.respons.to press. amines.  Dosage: Hypertens: Init.2,5 mg dly in pts.not on diuret. Incr.to 5 mg   Hypertens: Init. 25 mg 2-3xdly. Incr.to 50 mg 2-3xdly.aft.2 wks.if
       See also MDR page 71.         and max.10 mg dly at 1-2 wk. interv.depend.on respon.  necces. Max: 150 mg dly.
       ALAPREN, Ranbaxy [P/S]        Post MI: Init. 2,5 mg 2xdly x2 days 3-10 days aft.ac.MI if heart fail   Heart fail: Init. 6,25-12,5 mg 3xdly, incr.grad. over 1-2 wks.to 75-
                                     manifests & pt. haemodynamic stable.incr.to 5 mg 2xdly if well tol. If
                                                                  300 mg dly.
       Enalapril mal.                init. dos.of 2,5 mg not tol.init.with 1,25 mg 2xdly incr. to 2,5 mg 2xdly.  Contraindications: Hypersens.to other ACE inhibit., safety in chil-
       Indications: Hypertens., CHF in combinat.with diuret.& digital.,   High risk. indiv:   dr.und.18 yrs.not est., hist.of angioneurot.oed.with prev.ACE inhib.
       asymptomat.L ventricul.dysfunct.  Non-diabet.& diabet.nephropathy: Init. 1,25 mg dly. Accord.to   ther., pregn. & lactat.
       (S3) TABS, 34/7.1.3/0014, 0015, 0016  respons.doubl.dos.at 2-3 wk.interv. Max.10 mg dly.  Side effects: Angioed., proteinur.predomin.in those with prior ren.
       881473-006: 5 mg, 28, R23,99  Diuret.pre-treat.pts: Discont.diuret.2-3 days bef. init ther. Where di-  fail./high dos., nephrot.syndr., neutropen, elev.ser.K partic.in ren.fail.&
       881481-009:10 mg, 28, R41,24  uret.cannot.be discont.init.with. 1,25 mg adjust.accord.to BP respons.  diab. mellit., hypotens.episod., skin reacts, GI disturbs., hepatocellul.
       881503-002: 20 mg, 28, R54,69  MI/stroke/CV death risk reduct.: Init: 2,5 mg once dly. Incr.grad.  injury or cholest.jaund., proteinur., bld. dyscras., irrit.cough, hypotens.,
       Dosage: Indiv.                depend.on tol.in which case dos. should be doubl.aft.one wk.& doubl.  tachycard.& palpitat., anaphylact.reacts.dur.high-flux membr. dialys.,
       Essent.hypertens: Init.10-20 mg dly. Maint: 20 mg dly.  again aft.3 wks. to usual maint.dos.of 10 mg once dly.  paraesth.of hands, serum sickn., bronchosp., lymphadenopathy.
       Renovasc.hypertens: Init.5 mg or less. Most pts.respond.to   Contra-indications: Angio-oed.hist.relat.to prev. ACE inhibit.ther./  Special precautions: Imp.ren.funct., urine prot. estimat.with
       20 mg dly.                    angiotens.recept.block., heredit./ idiopathic angioed., aort.stenos.,   dos.&gt;150 mg dly./prior ren.dis., pts. to report any infect./ signs there-
       HF/asymptomat.L.ventric.dysfunct: Init. 2,5 mg dly.incr.grad.to   hypertrop. obstruct. cardiomyopathy, sev imp.ren funct., ren. ar-  aft.immed., pts. with collag.vasc.dis/ expos.to other meds.affect.
       usual maint.dos.of 10-20 mg as sngl.dos./2 div.dos.as tol.titr.over   tery stenos.in pts.with sngl.kidn., concom.K  spar. diuret.ther., por-  white cells/immunosuppress.ther.& imp.ren. funct., monit.WBC of
                                                       +
       a period of 2-4 wks.          phyr., safety & effic in childr. not est., pregn., safety in lactat.not est.  pts.at risk prior to ther., every 2 wks.,dur.1st 3 mnths.& period.there-
       Contra-indications: Angioneurot.oed.hist.relat. to prev.ACE inhibit.  Side-effects: Angioed., bld.dyscras., orthostat. effs., tachycard., dizz.,   aft.& discont. if neutrophil count falls bel.1000/ mm , K-spar. diuret./
                                                                                        3
       treatm., pregn., aortic.stenos., outflow tract obstruct., paed.use not   headache, fatig, mood.alt, ment.confus., paraesthes., sleep disturbs.,   med.assoc.with incr.serum K., vol.deplet. pts., monit.hypotens.esp.
       studied, concom.Ca antagon.not recomm.  hyperkalaem., hyponatraem., GI disturbs., ren. dysfunct., ac.ren.fail.,   with diuret.ther., low.init. dos.in pts.already receiv.diuret., concom.
       Side-effects: Sev.hypotens., ren.fail., CNS effs., asthen., hypotens.,   hepatit., jaund., asthen., cough., bronchosp., rhinit., sinusit., skin re-  Na restrict. benefic.in monother., loop diuret.pref.in ren. fail., aort.
       syncope, GI disturbs., musc. cramps, rash, cough, ren.dysfunct., CV disor-  acts.incl tox. epiderm.necrolysis/Stevens Johnson syndr.& erythema   stenos., surg./anaesth., agents with vasodilat. activ./aff.sympathetic.
       ds. incl. MI/CVA poss.second.to excess. hypotens. in high risk pts., nerv./  multif., psorias., allerg.reacts.  activ., monit. serum Li lev.
       resp./skin disords., impot., flush., taste alterat., tinnit., glossit., blurr.  Special precautions: Cerebrovasc./ischaem. heart dis., salt/vol.  Drug interactions: K-spar.diuret.incr.serum K, indomethacin & other
       vis., fev., serosit., vasculit., myalg., arthralg., arthrit., bld. disords., pho-  deplet. pts., sev.autoimmune dis., ac.MI with evid.of ren.fail./at   NSAIDs may reduc. antihypertens.eff., incr.serum Li lev.& risk of Li
       tosens., hypersens., angioneurot. oed., hyperkalaem. & hyponatraem.  risk of hypotens., bone marrow.depress., diab.mellit., hyperkalaem.,   toxic.incr.with concom.diuret.
       Special precautions: Lactat as secret.in breast milk, diuret.ther.,   imp.ren.funct., anaplylact.reacts. with desensitis.protocols/high flux   Warnings: Pass.through placenta.
       vol./salt deplet.pts., elderly, monit. BP,ren.funct.&serum K in HF, ren.  membr.dialys./ low dens.lipoprot.apheres.with dextr.sulph., incr. incid.
       impairm., ischaem. heart dis./cerebrovasc.dis.,angioed.hist., desen-  of angioed.in black pts., surg.& anaesth.  CIPLA PERINDOPRIL, Cipla Medpro [P/S]
       sitisat.with hymenoptera venom, poss. anaphylact. reacts. in pts.di-  Drug interactions: K -supplem./-spar.diuret. incr. hyperkalaem.  Perindopril tertbutylamine
                                               +
       ayls.with high flux membr., surg./anaesthes., concom.ganglion. block.   risk, diuret.& antihypertens.potent. respons., antihypertens.eff.decr.  Indications: Mild to mod.hypertens., CHF not adeq. control.with
       agents/ adrenerg.block.agents., diab. mellit., concom.K-supplem./K-  by NSAIDs, Li-conc. incr.  diuret.& digital.& where vasodilat. indicat
             +
       spar.diuret.& K  contain.salt substit.                     (S3) TABS, 41/7.1.3/0674, 0675
       Drug interactions: Other antihypertens./diuret. incr.eff., ß-adrenerg.  BINDACE, Novagen [P/S]  710302-001: 4 mg, 30, R173,86
       agents/methyldopa/Ca entry block. potent.hypotens.eff., Li eliminat.  Perindopril tertbutylamine  710510-001: 8 mg, 30, R173,87
       reduc., narcot.&antipsychot.may cause postur.hypotens., incr.leuco-  Indications: Mild to mod.hypertens., CHF not adeq. control.with   Dosage: Mild to mod.hypertens: 4 mg dly.bef. breakf., may be
       pen.risk with allopurin./cytostat/ immunosuppress.agents/ system.  diuret.& digital.& where vasodilat. indicat  incr.to 8 mg as sngl.dos.aft.1 mnth. of treatm.
       corticoster./ procainamide., cyclospor.incr.hyperkalaem.risk, NSAID’s   (S3) TABS, 43/7.1.3/1040, 1041  CHF: Init. 2 mg as sngl.dos.in morn., may be incr.to 4 mg once BP accept.
       may reduc./abolish antihypertens.eff., sympathomimet.may reduc.  717293-001: 4 mg, 30, R92,18  Contraindications: Angioed.hist.assoc.with prev. ACE-inhibit.ther./
       antihypertens.eff., alcoh. enhanc.hypotens.eff.  717294-001: 8 mg, 30, R138,02  angiotens.recept.block.ther., heredit./ idiopath.angioed., aort.stenos.,</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page135.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page131.html">131</a>&nbsp;&nbsp;&nbsp;<a href="page132.html">132</a>&nbsp;&nbsp;&nbsp;<a href="page133.html">133</a>&nbsp;&nbsp;&nbsp;<a href="page134.html">134</a>&nbsp;&nbsp;&nbsp;<a href="page135.html">135</a>&nbsp;&nbsp;&nbsp;<a href="page136.html">136</a>&nbsp;&nbsp;&nbsp;<a href="page137.html">137</a>&nbsp;&nbsp;&nbsp;<a href="page138.html">138</a>&nbsp;&nbsp;&nbsp;<a href="page139.html">139</a>&nbsp;&nbsp;&nbsp;<a href="page140.html">140</a>&nbsp;&nbsp;&nbsp;<a href="page141.html">141</a>
             </td>
             <td width="35%"><a href="page137.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page137.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
